The new chief financial officer of Tissue Regenix Group PLC (LON:TRX) has joined regenerative medical devices company a month earlier than expected.
Gareth Jones’ appointment was first unveiled back in July and he was originally scheduled to take up his new role at the end of November.
READ: Tissue Regenix appoints new CFO
But he has already completed the handover process in his previous position as the chief number cruncher at Applied Graphene Materials PLC (LON:AGM).
“I am delighted to welcome Gareth to the group,” said chief executive Steve Couldwell.
“He will play a pivotal role in the strategic direction, focus and acceleration of our commercial success.
He added: “Utilising his experience and knowledge of both operational and financial enhancement initiatives, alongside his international and listed company experience, we expect Gareth to help execute on our vision and accelerate sustainable long-term shareholder value.”